Zoetis Inc.

Equities

ZTS

US98978V1035

Market Closed - Nyse Other stock markets 00:00:03 22/01/2026 +03			5-day change	1st Jan Change
125.08 ^USD	+1.49%		-0.60%	-0.59%

01-13	Zoetis CEO on Animal Health, Vaccines and Beef Prices	MT
01-12	Zoetis Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 10:30 AM

Transcript : Zoetis Inc. - Special Call

Published on 12/02/2025 at 06:38 pm +03 - Modified on 12/02/2025 at 07:37 pm +03

S&P Capital IQ

Presenter Speech
Kristin Peck (Executives)

Good morning, everyone, and welcome to our Innovation Webcast. It's truly an exciting time for animal health. Across our industry, we're seeing remarkable

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Zoetis Inc.

01-13	Zoetis CEO on Animal Health, Vaccines and Beef Prices	MT
01-12	Zoetis Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 10:30 AM
12-17	Morgan Stanley Adjusts Zoetis Price Target to $160 From $175, Maintains Overweight Rating	MT
12-16	Sector Update: Health Care Stocks Edge Higher Premarket Tuesday	MT
12-16	The Fed's Favorite Numbers?
12-16	Zoetis Prices $1.75 Billion Convertible Notes Offering	MT
12-16	Zoetis says co priced offering of $1.75 billion aggregate principal amount of 0.25% convertible senior notes due 2029	RE
12-15	Zoetis to Offer $1.75 Billion Convertible Notes Offering	MT
12-15	Zoetis announces proposed $1.75 billion convertible senior notes offering	RE
12-15	BofA Securities Downgrades Zoetis to Neutral From Buy	MT
12-15	Zoetis shares fall 2.6% premarket after co announces proposed $1.75 billion convertible senior notes offering	RE
12-12	Zoetis Ups Quarterly Dividend to $0.53 per Share, Payable Mar. 3 to Holders of Record on Jan. 20	MT
12-12	Zoetis declares first quarter 2026 dividend; board approves 6% payment increase	RE
12-12	Zoetis Inc. Declares Dividend for the First Quarter of 2026, Payable on March 3, 2026	CI
12-10	HSBC Adjusts Zoetis Price Target to $140 From $180, Maintains Buy Rating	MT
12-09	Barclays Initiates Zoetis at Equalweight With $136 Price Target	MT
12-05	Zoetis Says Health Canada Approves Long-Lasting Cat Osteoarthritis Drug	MT
12-05	Zoetis Inc. Receives Health Canada Approval for Portela?? (Relfovetmab Injection) to Alleviate Pain Associated with Osteoarthritis in Cats	CI
12-05	Zoetis receives Health Canada approval for Portela (Relfovetmab injection)	RE
12-04	Zoetis Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-04-2025 09:30 AM
12-03	TD Cowen Adjusts Zoetis Price Target to $150 From $189, Maintains Buy Rating	MT
12-03	Rothschild & Co Redburn Adjusts Price Target on Zoetis to $165 From $195, Maintains Buy Rating	MT
12-02	Zoetis Inc. - Special Call
11-27	Zoetis receives European Commission marketing authorization for Lenivia (izenivetmab) to reduce pain associated with osteoarthritis (OA) in dogs	RE
11-27	Zoetis Inc. Receives European Commission Marketing Authorization for Lenivia®? (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs	CI